A 65-year-old female with a history of chronic kidney disease presents with severe hyperkalemia (serum potassium level of 6.8 mEq/L), hyponatremia (serum sodium level of 128 mEq/L), and metabolic acidosis (pH 7.28, bicarbonate 18 mEq/L). The ECG shows peaked T waves and widening of the QRS complex. What is the priority nursing action to address the patient's current condition?

A) Administer intravenous calcium gluconate to stabilize cardiac membranes.

B) Initiate a continuous infusion of insulin and dextrose to lower serum potassium.

C) Prepare the patient for emergent hemodialysis to correct electrolyte imbalances.

D) Administer intravenous sodium bicarbonate to correct metabolic acidosis.

A patient with chronic kidney disease presents with severe hyperkalemia, hyponatremia, and metabolic acidosis. The ECG shows peaked T waves and a widened QRS complex. What is the priority nursing intervention to address the patient's electrolyte imbalance and prevent further cardiac complications?

D) Administer intravenous calcium gluconate to stabilize cardiac membranes.

A) Administer oral sodium bicarbonate to correct metabolic acidosis.

B) Prepare the patient for emergency hemodialysis to quickly reduce potassium levels.

C) Initiate an infusion of hypertonic saline to correct hyponatremia.

D) Administer intravenous calcium gluconate to stabilize cardiac membranes.

A patient with severe hyperkalemia has developed new-onset atrial fibrillation and hypotension after receiving treatments including calcium gluconate, insulin with glucose, and a loop diuretic. The patient's potassium level has improved to 5.5 mEq/L, but their serum sodium is low at 130 mEq/L. Which of the following interventions should the nurse prioritize to address the patient's current clinical status?

C) Initiate continuous cardiac monitoring and prepare for potential cardioversion

A) Administer hypertonic saline to correct hyponatremia

B) Increase loop diuretic dosage to enhance potassium excretion

C) Initiate continuous cardiac monitoring and prepare for potential cardioversion

D) Initiate vasopressor therapy to manage hypotension

A patient with severe hyperkalemia and newly diagnosed atrial fibrillation is experiencing hypotension despite initial potassium correction. What is the most appropriate next step in managing her fluid and electrolyte balance to stabilize her hemodynamic status?

C) Administer hypertonic saline cautiously to address the hyponatremia and stabilize blood pressure

A) Administer additional insulin and glucose to further decrease serum potassium levels

B) Initiate a continuous infusion of a beta-blocker to control the atrial fibrillation

C) Administer hypertonic saline cautiously to address the hyponatremia and stabilize blood pressure

D) Increase the dose of loop diuretic to enhance potassium excretion and manage fluid overload

A patient with worsening renal function and metabolic acidosis exhibits fluctuating blood pressure and episodes of atrial fibrillation with bradycardia. Considering the current clinical picture, which nursing intervention should be prioritized to stabilize the patient's condition?

B) Initiate continuous renal replacement therapy (CRRT) to address electrolyte imbalances.

A) Administer a calcium channel blocker to manage atrial fibrillation.

B) Initiate continuous renal replacement therapy (CRRT) to address electrolyte imbalances.

C) Increase intravenous fluid administration to stabilize blood pressure.

D) Administer sodium bicarbonate to correct metabolic acidosis.

The patient is experiencing renal impairment, metabolic acidosis, and cardiac instability, including episodes of atrial fibrillation and bradycardia. Which of the following interventions would be the most appropriate initial step to address the metabolic acidosis while considering the patient's complex clinical condition?

B) Begin continuous renal replacement therapy (CRRT) to manage electrolyte imbalances and support renal function.

A) Initiate a continuous infusion of sodium bicarbonate to correct the metabolic acidosis.

B) Begin continuous renal replacement therapy (CRRT) to manage electrolyte imbalances and support renal function.

C) Administer a bolus of intravenous normal saline to improve renal perfusion and correct hypotension.

D) Increase the dose of vasoactive medications to stabilize the blood pressure before addressing the acidosis.

A patient in the ICU is experiencing a drop in Glasgow Coma Scale (GCS) score from 14 to 10, sluggish pupillary reactions, and disorientation. Her labs show a serum potassium level of 6.2 mEq/L and a sodium level of 128 mEq/L. Continuous Renal Replacement Therapy (CRRT) has been initiated to manage her electrolyte imbalances. Which nursing intervention is most critical to prioritize in this scenario?

B) Increase fluid administration to correct hyponatremia rapidly.

C) Prepare the patient for immediate hemodialysis to rapidly lower potassium levels.

D) Monitor neurological status closely and prepare for possible intubation due to declining mental status.

A patient admitted with electrolyte imbalances is exhibiting increasing lethargy and disorientation, with a recent drop in the Glasgow Coma Scale (GCS) score to 10. Her lab results reveal hyperkalemia and hyponatremia. The interdisciplinary team has initiated continuous renal replacement therapy (CRRT). As the nurse, which of the following interventions is the highest priority in managing this patient's current condition?

A) Administer calcium gluconate to stabilize the cardiac membrane.

C) Monitor for signs of cerebral edema due to hyponatremia.

D) Expedite imaging studies to rule out acute intracranial events.

A patient undergoing continuous renal replacement therapy (CRRT) presents with persistent hyperkalemia and dilutional hyponatremia, with a Glasgow Coma Scale (GCS) score of 11. Despite treatment, her serum sodium is 130 mEq/L, and ECG shows peaked T waves. Which nursing intervention should take priority to address the immediate risks associated with her condition?

B) Administer an additional dose of calcium gluconate to stabilize cardiac membranes.

A) Increase the flow rate of CRRT to rapidly correct sodium levels.

B) Administer an additional dose of calcium gluconate to stabilize cardiac membranes.

C) Initiate a sodium bicarbonate infusion to correct potential metabolic acidosis.

D) Implement seizure precautions due to the risk of neurological deterioration.

A patient undergoing continuous renal replacement therapy (CRRT) for acute kidney injury presents with episodes of ventricular ectopy and peaked T waves on ECG, indicating hyperkalemia. Despite treatment with calcium gluconate and insulin with glucose, the patient's serum potassium level remains elevated. What is the most appropriate next step in managing this patient's hyperkalemia?

C) Initiate hemodialysis to rapidly lower potassium levels.

A) Increase the rate of CRRT to enhance potassium clearance.

B) Administer a dose of sodium bicarbonate to shift potassium intracellularly.

C) Initiate hemodialysis to rapidly lower potassium levels.

D) Continue current treatment and monitor for further arrhythmic events.

Fluid and Electrolyte Imbalances - Nursing Case Study

Pathophysiology

• Primary mechanism: Disruption in osmotic gradients due to sodium imbalance alters fluid distribution, causing cellular dehydration or edema; hypernatremia draws water out of cells, while hyponatremia leads to fluid overload and cellular swelling.

• Secondary mechanism: Altered renal function impairs electrolyte filtration and reabsorption; kidney injury or disease reduces the ability to excrete potassium, leading to hyperkalemia, which can cause severe cardiac dysrhythmias.

• Key complication: Severe imbalances, such as hypercalcemia, disrupt neuromuscular function and precipitate life-threatening conditions such as cardiac arrest due to impaired cardiac contractility and conduction abnormalities.

Patient Profile

Demographics:

58-year-old female, retired nurse

History:

• Key past medical history: Chronic kidney disease stage 4, hypertension, type 2 diabetes mellitus, congestive heart failure

• Current medications: Lisinopril, Metformin, Furosemide, Insulin glargine, Amlodipine

• Allergies: Sulfa drugs

Current Presentation:

• Chief complaint: Severe fatigue and confusion

• Key symptoms: Edema, muscle cramps, nausea, decreased urine output, irregular heartbeat

• Vital signs: Blood pressure 95/60 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, temperature 101.3°F, oxygen saturation 88% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, a series of diagnostic tests were ordered to further investigate the underlying causes of the patient's presenting symptoms and to guide the management plan. Laboratory results reveal a serum sodium level of 128 mEq/L, indicating hyponatremia, and a serum potassium level of 6.8 mEq/L, pointing to severe hyperkalemia. The patient's blood urea nitrogen (BUN) and creatinine levels are significantly elevated at 70 mg/dL and 4.5 mg/dL, respectively, confirming exacerbation of her chronic kidney disease. Additionally, arterial blood gas analysis shows metabolic acidosis with a pH of 7.28, bicarbonate level of 18 mEq/L, and a partial pressure of carbon dioxide (PaCO2) of 32 mmHg. The electrocardiogram (ECG) displays peaked T waves, widening of the QRS complex, and a prolonged PR interval, all indicative of the dangerous cardiac effects of hyperkalemia.

In light of these findings, the healthcare team must prioritize the correction of the electrolyte imbalances, particularly the hyperkalemia, due to its immediate threat to cardiac function. The presence of hyponatremia complicates the fluid management strategy, requiring careful consideration to avoid exacerbating cerebral edema or worsening cardiac output. Given the metabolic acidosis, the team should evaluate the need for bicarbonate therapy, while also considering the role of dialysis in managing the renal failure and severe electrolyte disturbances. These results necessitate a coordinated approach involving nephrology, cardiology, and critical care to stabilize the patient and mitigate the risk of further life-threatening complications.

Section 2

As the healthcare team initiates treatment, the patient is started on calcium gluconate to stabilize cardiac membranes, followed by insulin and glucose infusions to facilitate the intracellular shift of potassium. Concurrently, she receives a low-dose loop diuretic to promote renal excretion of potassium, while careful monitoring of her fluid status is maintained due to the risk of volume overload. The nephrology team is consulted promptly, and urgent hemodialysis is arranged to address both the severe hyperkalemia and worsening renal function. Sodium bicarbonate is administered cautiously to correct metabolic acidosis, with frequent arterial blood gas assessments to evaluate the response.

Within the next few hours, the patient exhibits a change in status. Her heart rate becomes irregular, and she experiences episodes of palpitations and dizziness. Repeat ECG confirms the presence of new atrial fibrillation, likely secondary to electrolyte imbalances and underlying cardiac stress. Her blood pressure begins to fluctuate, with episodes of hypotension complicating her hemodynamic stability. Despite initial improvements in potassium levels, now at 5.5 mEq/L, her serum sodium remains low at 130 mEq/L, necessitating a reevaluation of her fluid management strategy. The critical care team deliberates on the risks and benefits of hypertonic saline administration, balancing the need for sodium correction against potential complications such as osmotic demyelination syndrome.

These developments prompt an urgent review of her treatment plan, requiring advanced clinical reasoning to navigate the intertwined challenges of electrolyte correction, cardiac stability, and renal support. The focus intensifies on titrating interventions to stabilize her cardiovascular system while continuing to address her renal and electrolyte imbalances. As the team prepares for potential escalation, including more aggressive dialysis or cardiac support, they remain vigilant for any signs of further deterioration, emphasizing the critical need for continual reassessment and interdisciplinary collaboration.

Section 3

As the medical team intensifies their efforts to stabilize the patient, a new set of diagnostic results returns, shedding light on her evolving condition. Notably, the latest serum chemistry panel reveals a slight increase in creatinine levels to 3.5 mg/dL, indicating a further decline in renal function despite ongoing interventions. The blood urea nitrogen (BUN) level has also risen to 45 mg/dL, corroborating the worsening renal impairment. Additionally, the arterial blood gas analysis indicates a pH of 7.28, with a partial pressure of carbon dioxide (PaCO2) at 35 mmHg, and bicarbonate (HCO3-) level at 16 mEq/L, confirming the persistence of metabolic acidosis. These findings underscore the urgency of reassessing the patient's fluid and electrolyte management strategy, as well as the potential need to escalate renal support.

Concurrently, the patient's heart rate has become increasingly erratic, with episodes of atrial fibrillation interspersed with periods of bradycardia, suggestive of worsening cardiac instability. Her blood pressure remains labile, with systolic readings fluctuating between 85 to 110 mmHg, despite careful titration of intravenous fluids and vasoactive medications. The irregular rhythm and hemodynamic instability prompt a thorough review of her medication regimen, particularly the potential role of ongoing electrolyte imbalances in precipitating cardiac disturbances. The team considers initiating a low-dose beta-blocker to manage the atrial fibrillation while maintaining vigilance for exacerbation of her hypotension.

These developments complicate the patient's management, necessitating a more nuanced approach that integrates her cardiac, renal, and metabolic challenges. The healthcare team debates the possibility of more frequent or continuous renal replacement therapy to better control her electrolyte levels and support her renal function. In the meantime, they remain vigilant for signs of volume overload or further hemodynamic compromise, poised to adjust their strategy in response to the patient's dynamic condition. This evolving clinical picture highlights the intricate balance required to navigate her complex medical needs, demanding continuous interdisciplinary collaboration and expert clinical judgment.

Section 4

As the healthcare team continues to monitor the patient closely, a change in her status becomes apparent. During a routine assessment, the nurse notices that the patient is becoming increasingly lethargic and disoriented, with a Glasgow Coma Scale (GCS) score now dropping to 10 from the previous 14. Neurological checks reveal sluggish pupillary reactions and a decrease in her ability to respond to verbal commands, raising concerns about cerebral perfusion and potential electrolyte-induced neurotoxicity. These alarming findings prompt an immediate re-evaluation of her electrolyte levels, as well as a decision to expedite imaging studies to rule out any acute intracranial events.

Simultaneously, a new set of laboratory results reveals a marked increase in serum potassium, now at 6.2 mEq/L, exacerbating the risk of life-threatening cardiac arrhythmias. Her sodium level has decreased further to 128 mEq/L, indicating a possible dilutional hyponatremia secondary to aggressive fluid resuscitation. The patient's magnesium level, however, remains within normal limits, eliminating it as a contributor to her neurological deterioration. These lab abnormalities necessitate an urgent adjustment in her fluid and electrolyte management, with discussions centered around administering calcium gluconate to stabilize cardiac membranes and initiating insulin and glucose therapy to facilitate intracellular potassium shift.

In response to these developments, the interdisciplinary team agrees to commence continuous renal replacement therapy (CRRT) to better control her electrolyte derangements and prevent further renal decline. The initiation of CRRT is accompanied by cautious fluid management, balancing her need for volume support against the risk of exacerbating her hyponatremia and causing cerebral edema. As the team implements these interventions, they remain watchful for any further deterioration in her neurological status or cardiac rhythm, aware that each decision must be finely tuned to the complex interplay of her evolving clinical picture.

Section 5

As the continuous renal replacement therapy (CRRT) is initiated, the team closely observes the patient's response to this intervention. Within the first few hours, there is a mild improvement in her lethargy; however, her neurological status remains a concern. Repeat neurological assessments show a slight improvement in her Glasgow Coma Scale (GCS) score, now at 11, yet she remains disoriented and her pupillary reactions are still sluggish. The team deliberates the potential for cerebral edema due to the dilutional hyponatremia and carefully adjusts the CRRT parameters to ensure a gradual correction of her sodium levels. Despite these efforts, the patient's serum sodium remains at 130 mEq/L, requiring meticulous monitoring to prevent rapid shifts that could worsen her condition.

Simultaneously, the cardiac monitor alarms, indicating episodes of ventricular ectopy. An urgent electrocardiogram (ECG) reveals peaked T waves, consistent with hyperkalemia, but fortunately no sustained arrhythmias are observed. The team promptly administers a second dose of calcium gluconate, along with additional insulin and glucose therapy, to address the persistent hyperkalemia. Continuous telemetry monitoring is implemented to detect any significant arrhythmias that may necessitate more aggressive interventions, such as antiarrhythmic medications or temporary pacing.

As the patient remains on CRRT, her urine output is minimal, reinforcing the suspicion of acute kidney injury contributing to her electrolyte imbalances. Lab results continue to be monitored hourly, with a focus on trending potassium and sodium levels, as well as assessing her acid-base balance given the risk of metabolic acidosis. The interdisciplinary team remains vigilant, coordinating with nephrology, cardiology, and neurology specialists to ensure that all aspects of her care are optimized. Each intervention is weighed carefully, recognizing that the balance between correcting her electrolyte disturbances and preventing further neurological or cardiac complications requires precise clinical judgment.